CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy
Johnson & Johnson (J&J) is investing more than $785 million (approximately 1.11 trillion won) in next-generation "in vivo CAR-T" technology designed...
Search results for "Clinic"
Chong Kun Dang’s CKD-339 Enters Phase 3 in South Korea for Patients Uncontrolled on Monotherapy
CKD-339, an essential hypertension treatment under development by Chong Kun Dang, is advancing into a Phase 3 clinical trial in South Korea.
South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway
"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
Placebo Outperforms TG-C: Data Errors and Stock Volatility Cloud Kolon TissueGene’s Phase 3 Trial
Kolon TissueGene’s knee osteoarthritis cell and gene therapy, TG-C, has failed to achieve statistical significance on...
Medical AI Can Explain Its Decisions—but Can Clinicians Trust Its Reasons?
Artificial intelligence in medical imaging can analyze brain magnetic resonance imaging scans not only to estimate...
Daegu Wins Bid to Host 2034 World Congress of Basic & Clinical Pharmacology
Daegu has been selected to host the 2034 World Congress of Basic & Clinical Pharmacology (WCP 2034), marking the first...
Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines
South Korean regulators have revised requirements to significantly reduce the time and financial burden of biosimilar...
Half a Century of Care: How H Plus Yangji Hospital Rose from a Neighborhood Clinic to a Global Gateway
Gwanak-gu in southern Seoul holds the highest concentration of single-person households among young adults in their 20s...
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...